Qiang Bo

Bowen Gao, Bo Qiang, Haichuan Tan et al.

Virtual screening, which identifies potential drugs from vast compound databases to bind with a particular protein pocket, is a critical step in AI-assisted drug discovery. Traditional docking methods are highly time-consuming, and can only work with a restricted search library in real-life applications. Recent supervised learning approaches using scoring functions for binding-affinity prediction, although promising, have not yet surpassed docking methods due to their strong dependency on limited data with reliable binding-affinity labels. In this paper, we propose a novel contrastive learning framework, DrugCLIP, by reformulating virtual screening as a dense retrieval task and employing contrastive learning to align representations of binding protein pockets and molecules from a large quantity of pairwise data without explicit binding-affinity scores. We also introduce a biological-knowledge inspired data augmentation strategy to learn better protein-molecule representations. Extensive experiments show that DrugCLIP significantly outperforms traditional docking and supervised learning methods on diverse virtual screening benchmarks with highly reduced computation time, especially in zero-shot setting.

Bo Qiang, Chengyue Gong, Xinshi Chen et al.

Lightweight inference is critical for biomolecular structure prediction and downstream tasks, enabling efficient real-world deployment and inference-time scaling for large-scale applications. While AF3 and its variants (e.g., Protenix, Chai-1) have advanced structure prediction results, they suffer from critical limitations: high inference latency and cubic time complexity with respect to token count, both of which restrict scalability for large biomolecular complexes. To address the core challenge of balancing model efficiency and prediction accuracy, we introduce three key innovations: (1) compressing non-scalable operations to mitigate cubic time complexity, (2) removing redundant blocks across modules to reduce unnecessary overhead, and (3) adopting a few-step sampler for the atom diffusion module to accelerate inference. Building on these design principles, we develop Protenix-Mini+, a highly lightweight and scalable variant of the Protenix model. Within an acceptable range of performance degradation, it substantially improves computational efficiency. For example, in the case of low-homology single-chain proteins, Protenix-Mini+ experiences an intra-protein LDDT drop of approximately 3% relative to the full Protenix model -- an acceptable performance trade-off given its substantially 90%+ improved computational efficiency.